The triple combination of HK2-antisense oligonucleotide (ASO1), OXPHOS inhibitor diphenyleneiodonium (DPI), and FAO inhibitor perhexiline prevents the growth of multiple myeloma tumor xenografts and can achieve synthetic lethality in tumor cells 60. Here, HK2 is linked to neoplasm.